CareDx, Inc. (CDNA) Cash Flow Statement
CareDx, Inc. (CDNA) generated $93.7M of operating cash flow over the twelve months to 2026-06-30, spent $57.5M on capital expenditure and had free cash flow of $36.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CDNACareDx, Inc.Follow CDNA — free
—
Price chart with a free account
- Market cap
- 3.6B
- P/E TTM
- 33.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -3.4 | -9.8 | -16.5 | -14.3 | -4.0 | -2.8 | 33.4 | -19.3 | -25.2 | -18.4 | 38.0 | 42.0 | 93.7 | |
| Capital expenditure | 0.7 | 1.2 | 0.5 | 0.2 | 2.0 | — | — | 13.6 | 21.2 | 8.3 | 6.5 | 5.9 | -57.5 | |
| Free cash flow | -4.1 | -11.0 | -17.1 | -14.5 | -6.0 | — | — | -32.9 | -46.5 | -26.7 | 31.6 | 36.1 | 36.1 | |
| Share repurchases | — | — | — | — | — | — | — | — | 0.6 | 27.5 | 0.5 | 87.8 | — | |
| Stock-based compensation | 0.5 | 1.3 | 2.0 | 1.7 | 7.1 | 22.4 | 23.4 | 36.1 | 46.6 | 49.1 | 66.4 | 34.9 | — |
USD millions · SEC XBRL
CareDx, Inc. — questions
- What is CareDx, Inc.'s operating cash flow?
- $93.7M over the twelve months to 2026-06-30.
- How much does CareDx, Inc. spend on capital expenditure?
- $57.5M over the twelve months to 2026-06-30.
- What is CareDx, Inc.'s free cash flow?
- $36.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from CareDx, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.